[HTML][HTML] Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19: Joint guideline of Associação Brasileira de Medicina de …

M Falavigna, C Stein, JLG Amaral… - Revista Brasileira de …, 2022 - SciELO Brasil
Objective: Several therapies are being used or proposed for COVID-19, and many lack
appropriate evaluations of their effectiveness and safety. The purpose of this document is to …

[HTML][HTML] Predictors of high flow oxygen therapy failure in COVID-19-related severe hypoxemic respiratory failure

E Polydora, M Alexandrou, S Tsipilis… - Journal of Thoracic …, 2022 - ncbi.nlm.nih.gov
Background During COVID-19 pandemic, people who developed pneumonia and needed
supplemental oxygen, where treated with low-flow oxygen therapy systems and non …

A patient-tailored approach for corticosteroid treatment in COVID-19: still not there yet

M Nigro, JD Chalmers, S Aliberti - European Respiratory …, 2023 - Eur Respiratory Soc
More than 3 years after its first appearance, severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) is still among the most troublesome respiratory viruses and the coronavirus …

Antiviral treatment selection for SARS-CoV-2 pneumonia

M Bassetti, S Corcione, S Dettori… - Expert Review of …, 2021 - Taylor & Francis
Introduction Therapy of coronavirus disease 2019 (COVID-19) involves evolving algorithms
that include drugs aimed at reducing disease progression by counteracting two different, but …

[HTML][HTML] Six-week hospital-based pulmonary rehabilitation in Covid pneumonia ICU survivors: Experience from a tertiary care center in central India

AK Khurana, A Hussain, A Goyal, ST Karna… - Turkish thoracic …, 2022 - ncbi.nlm.nih.gov
OBJECTIVE There is very limited data on the usefulness of pulmonary rehabilitation in
patients with coronavirus pneumonia who have survived intensive care unit care. The …

[HTML][HTML] Unmet needs in pneumonia research: a comprehensive approach by the CAPNETZ study group

MW Pletz, AV Jensen, C Bahrs, C Davenport… - Respiratory …, 2022 - Springer
Introduction Despite improvements in medical science and public health, mortality of
community-acquired pneumonia (CAP) has barely changed throughout the last 15 years …

World bronchiectasis day 2022

JD Chalmers, T Aksamit, S Aliberti… - European …, 2022 - Eur Respiratory Soc
World Bronchiectasis Day 2022 | European Respiratory Society Skip to main content Main
menu Home Current issue ERJ Early View Past issues ERS Guidelines Authors/reviewers …

[HTML][HTML] In-hospital survival of critically ill COVID-19 patients treated with glucocorticoids: a multicenter real-world data study

S Angermair, JH Hardenberg, K Rubarth, F Balzer… - Scientific Reports, 2024 - nature.com
The COVID-19 pandemic has posed a major challenge to healthcare systems globally.
Millions of people have been infected, and millions of deaths have been reported worldwide …

Pathogen evolution, prevention/control strategy and clinical features of COVID-19: experiences from China

D Wei, Y Xie, X Liu, R Chen, M Zhou, X Zhang… - Frontiers of Medicine, 2023 - Springer
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) was reported at the end of
2019 as a worldwide health concern causing a pandemic of unusual viral pneumonia and …

[HTML][HTML] Optimal timing for awake prone positioning in Covid-19 patients: Insights from an observational study from two centers

W Zhang, Y He, Q Gu, Y Zhang, Q Zha, Q Feng… - International Journal of …, 2024 - Elsevier
Background The widespread application and interest in awake prone positioning stems from
its ease and availability and its ability to enhance patients' oxygenation. Nevertheless, due …